Table 3

Cervical test positivity rates for various clinical groups

Cytological/histological diagnosis

TERC positive cases [% (positive/total)]

C-MYC positive cases [% (positive/total)]


NILM-negative

7.3 (8/109)

19.3 (21/109)

NILM-CIN1

0.0 (0/15)

33.3 (5/15)

NILM-CIN2+

37.5 (3/8)

37.5 (3/8)

ASCUS-negative

12.8 (5/39)

23.1 (9/39)

ASCUS-CIN1

14.3 (1/7)

14.3 (1/7)

ASCUS-CIN2+

100.0 (4/4)

75.0 (3/4)

LSIL-negative

18.2 (2/11)

36.4 (4/11)

LSIL-CIN1

75.0 (3/4)

50.0 (2/4)

LSIL-CIN2+

100.0 (6/6)

100.0 (6/6)

ASC-H-negative

0.0 (0/3)

0.0 (0/3)

ASC-H -CIN1

0.0 (0/2)

0.0 (0/2)

ASC-H -CIN2+

100.0 (9/9)

66.7 (6/9)

HSIL-negative

0.0 (0/2)

0.0 (0/2)

HSIL-CIN1

100.0 (1/1)

100.0 (1/1)

HSIL-CIN2+

100.0 (20/20)

95.0 (19/20)

SCC-CIN2+

100.0 (3/3)

100.0 (3/3)


Chen et al. Diagnostic Pathology 2012 7:40   doi:10.1186/1746-1596-7-40

Open Data